deltatrials
Completed PHASE4 NCT00189462

A Pilot Study to Evaluate the Efficacy of Montelukast in the Treatment of Acute Otitis Media (AOM) in Children

Sponsor: Deborah Gentile

Conditions Acute Otitis Media Ear Infection Otitis Media
Interventions Montelukast Placebo
Updated 9 times since 2017 Last updated: Oct 30, 2020 Started: Mar 31, 2004 Primary completion: Dec 31, 2005 Completion: Dec 31, 2005

This PHASE4 trial investigates Acute Otitis Media and Ear Infection and is currently completed. Deborah Gentile leads this study, which shows 9 recorded versions since 2004 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jun 2022 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jun 2022 [monthly]

    Completed PHASE4

  5. Dec 2020 — Jan 2021 [monthly]

    Completed PHASE4

▶ Show 4 earlier versions

  1. Nov 2020 — Dec 2020 [monthly]

    Completed PHASE4

  2. Jun 2018 — Nov 2020 [monthly]

    Completed PHASE4

  3. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE4

  4. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Mar 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Deborah Gentile
  • Merck Sharp & Dohme LLC
Data source: West Penn Allegheny Health System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bellevue, United States
  • • Pittsburgh, United States